- Home
- GLTO vs MOGU Comparison
GLTO vs MOGU Comparison
Compare GLTO & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLTO
- MOGU
- Stock Information
- Founded
- GLTO 2011
- MOGU 2011
- Country
- GLTO Denmark
- MOGU China
- Employees
- GLTO N/A
- MOGU N/A
- Industry
- GLTO Biotechnology: Pharmaceutical Preparations
- MOGU Business Services
- Sector
- GLTO Health Care
- MOGU Consumer Discretionary
- Exchange
- GLTO Nasdaq
- MOGU Nasdaq
- Market Cap
- GLTO 23.7M
- MOGU 19.8M
- IPO Year
- GLTO 2020
- MOGU 2018
- Fundamental
- Price
- GLTO $16.82
- MOGU $2.55
- Analyst Decision
- GLTO
- MOGU
- Analyst Count
- GLTO 0
- MOGU 0
- Target Price
- GLTO N/A
- MOGU N/A
- AVG Volume (30 Days)
- GLTO 3.4M
- MOGU 8.8K
- Earning Date
- GLTO 11-06-2025
- MOGU 11-21-2025
- Dividend Yield
- GLTO N/A
- MOGU N/A
- EPS Growth
- GLTO N/A
- MOGU N/A
- EPS
- GLTO N/A
- MOGU N/A
- Revenue
- GLTO N/A
- MOGU $19,462,964.00
- Revenue This Year
- GLTO N/A
- MOGU N/A
- Revenue Next Year
- GLTO N/A
- MOGU N/A
- P/E Ratio
- GLTO N/A
- MOGU N/A
- Revenue Growth
- GLTO N/A
- MOGU N/A
- 52 Week Low
- GLTO $2.01
- MOGU $1.83
- 52 Week High
- GLTO $33.60
- MOGU $8.10
- Technical
- Relative Strength Index (RSI)
- GLTO 55.60
- MOGU 43.62
- Support Level
- GLTO $15.76
- MOGU $2.54
- Resistance Level
- GLTO $29.03
- MOGU $2.65
- Average True Range (ATR)
- GLTO 4.83
- MOGU 0.14
- MACD
- GLTO -0.52
- MOGU 0.01
- Stochastic Oscillator
- GLTO 43.02
- MOGU 27.27
About GLTO Galecto Inc.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.